You have 9 free searches left this month | for more free features.

Leukemia,%20Plasma%20Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

Head and Neck Tumors Trial in Worldwide (biological, drug, radiation)

Active, not recruiting
  • Head and Neck Neoplasms
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +150 more
Dec 7, 2022

Reveal Patterns of Presentation, Management and Outcome of SCLC

Recruiting
  • Lung Cancer
    • Dammam, Saudi Arabia
    • +2 more
    Jul 25, 2022

    Lymphangioleiomyomatosis Trial in Spain (Loratadine, Placebo 10mg/day added to rapamycin for 12 months)

    Recruiting
    • Lymphangioleiomyomatosis
    • Loratadine
    • Placebo 10mg/day added to rapamycin for 12 months
    • Hospitalet de Llobregat, Barcelona, Spain
    • +5 more
    Jan 12, 2022

    Trial of Kidney Tx Patients Treated With Imlifidase or PE

    Recruiting
    • Kidney Transplant Rejection
    • Vienna, Austria
    • +4 more
    Apr 7, 2022

    Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

    Completed
    • Retinitis Pigmentosa
    • Wharton's jelly derived mesenchymal stemcells
    • Magnovision
    • Ankara, Gölbaşı, Turkey
    • +2 more
    Mar 23, 2023

    Relapsed/Refractory Diffuse Large B Cell Lymphoma, Relapsed/Refractory Primary Mediastinal B Cell Lymphoma, Relapsed/Refractory

    Approved for marketing
    • Relapsed/Refractory Diffuse Large B Cell Lymphoma
    • +3 more
    • Axicabtagene Ciloleucel
    • Duarte, California
    • +14 more
    Aug 30, 2022

    Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Perfusion CT scan
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 6, 2022

    NSCLC Trial in China (Atezolizumab, Placebo, Bevacizumab)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Beijing City, China
    • +22 more
    Dec 7, 2022

    Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +3 more
    • Toripalimab (anti-programmed death-1 inhibitor)
    • +4 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 8, 2022

    Intermittent Hypoxia Trial in Austin (Intermittent hypoxia, Intermittent normoxia)

    Completed
    • Intermittent Hypoxia
    • Intermittent hypoxia
    • Intermittent normoxia
    • Austin, Texas
      The Unviersity of Texas at Austin
    Jun 6, 2023

    Adenovirus Trial in Worldwide (Standard of Care, Brincidofovir)

    Terminated
    • Adenovirus
    • Los Angeles, California
    • +35 more
    Jan 5, 2021

    HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

    Not yet recruiting
    • HIV Infections
    • VH3810109
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Aug 9, 2023

    Non Small Cell Lung Cancer Trial in China (AZD3759)

    Completed
    • Non Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
    • +3 more
    Nov 22, 2022

    Malignancy, Malignant Tumor, Lymphoproliferative Disorders Trial in United Kingdom (Atezolizumab)

    Not yet recruiting
    • Malignancy
    • +8 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Safe Emergency Department dIscharGe Rate (SEIGE)

    Active, not recruiting
    • Acute Myocardial Infarction
    • Acute Coronary Syndrome
    • Cardiac Troponin Testing
    • Minneapolis, Minnesota
      Hennepin Healthcare Research Institute / Hennepin County Medical
    Jan 28, 2022

    Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,

    Recruiting
    • Head and Neck Cancer
    • +2 more
    • Enoblituzumab
    • +2 more
    • Baltimore, Maryland
    • +41 more
    May 16, 2022

    Sarcopenia, Sarcopenic Obesity, Diabetes Trial in Milan (mediterranean diet with adequate protein intake)

    Not yet recruiting
    • Sarcopenia
    • +4 more
    • mediterranean diet with adequate protein intake
    • Milan, Italy
      Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Jul 18, 2023

    Alopecia, Androgenetic, Hair Loss/Baldness Trial in Jakarta Pusat (Non-concentrated adipose-derived stem cell conditioned media

    Completed
    • Alopecia, Androgenetic
    • Hair Loss/Baldness
    • Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil
    • +2 more
    • Jakarta Pusat, Jakarta, Indonesia
      Universitas Indonesia
    Mar 15, 2022

    Chemo-induced Thrombocytopenia Trial in Worldwide (Avatrombopag, Placebo Oral Tablet)

    Active, not recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Anaheim, California
    • +54 more
    Nov 22, 2021

    Dilatation of Anastomosis, Bypass Complication, Obesity Trial in São José do Rio Prêto (Carbon dioxide, Ambient air, Argon

    Completed
    • Dilatation of Anastomosis
    • +2 more
    • Carbon dioxide
    • +2 more
    • São José do Rio Prêto, Sao Paolo, Brazil
      Kaiser Clinic and Day Hospital
    Aug 16, 2022

    Wilson Disease Trial in Austin (ALXN1840, Celecoxib)

    Completed
    • Wilson Disease
    • Austin, Texas
      Clinical Trial Site
    Nov 2, 2021

    RR DLBCL; PD-1; CD20 Trial (F520+F007)

    Not yet recruiting
    • RR DLBCL; PD-1; CD20
    • (no location specified)
    Dec 17, 2021

    Heart Transplantation Trial in Madrid (Autologous thyTreg)

    Recruiting
    • Heart Transplantation
    • Autologous thyTreg
    • Madrid, Spain
      Hospital General Universitario Gregorio Marañon
    Dec 5, 2022

    Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

    Not yet recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • +4 more
    • Near Infrared Imaging
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 5, 2022